loading page

Prognostic factors for COVID-19 patients
  • +14
  • Uğur Önal,
  • Özge Aydın Güçlü,
  • Halis AKALIN,
  • Nilüfer Aylin Acet Öztürk,
  • Cihan Semet,
  • Ezgi Demirdöğen,
  • Aslı Görek Dilektaşlı,
  • İmran Sağlık,
  • Esra Kazak,
  • Guven Ozkaya,
  • Funda Coşkun,
  • Dane Ediger,
  • Yasemin Heper,
  • Ahmet Ursavas,
  • Emel Yılmaz,
  • Esra Uzaslan,
  • Mehmet Karadağ
Uğur Önal

Corresponding Author:[email protected]

Author Profile
Özge Aydın Güçlü
Uludag University Faculty of Medicine
Author Profile
Halis AKALIN
Uludag University Faculty of Medicine
Author Profile
Nilüfer Aylin Acet Öztürk
Uludag University Faculty of Medicine
Author Profile
Cihan Semet
Uludag University Faculty of Medicine
Author Profile
Ezgi Demirdöğen
Uludag University Faculty of Medicine
Author Profile
Aslı Görek Dilektaşlı
Uludag University Faculty of Medicine
Author Profile
İmran Sağlık
Uludag University Faculty of Medicine
Author Profile
Esra Kazak
Uludag University Faculty of Medicine
Author Profile
Guven Ozkaya
Author Profile
Funda Coşkun
Uludag University Faculty of Medicine
Author Profile
Dane Ediger
Uludag University Faculty of Medicine
Author Profile
Yasemin Heper
Uludag University Faculty of Medicine
Author Profile
Ahmet Ursavas
Uludag University Faculty of Medicine
Author Profile
Emel Yılmaz
Uludag University Faculty of Medicine
Author Profile
Esra Uzaslan
Uludag University Faculty of Medicine
Author Profile
Mehmet Karadağ
Uludag University Faculty of Medicine
Author Profile

Abstract

Background: Determination of the prognostic factors which affects the mortality and morbidity in COVID-19 patients, has an importance in terms of planning the treatment and follow-up strategy. Material and Method: Patients who had COVID-19 diagnosis via microbiologically and/or radiologically between March and October 2020 in a tertiary-care university hospital were recorded retrospectively. Only adult patients (≥18 years) with clinical spectrum of moderate, severe and critical illness were included in the study according to National Institutes of Health (NIH) guideline. A p value of less than 0.05 was considered significant. Ethical committee approval was given from the Uludag University with decision number 2020-22/11. Also, the permission from Republic of Turkey, Ministry of Health was given. Results: A total number of 257 patients were included in the study. 30-day mortality rate was recorded as 14.4%. In univariate analysis; age, chronic renal failure, malignancy, cerebrovascular disease, number of comorbidities >2, dyspnea, cough, NIH severe and critical illness, oxygen saturation, respiratory rate, systolic and diastolic blood pressure, qSOFA, GCS, MEWS, SOFA, CURB-65, CCI, CRP, procalcitonin, CK, D-dimer, lymphocyte and thrombocyte levels, neutrophile-to-lymphocyte ratio, AST, albumin, hemoglobin, CK-MB, fibrinogen, LDH and potassium levels were found as statistically significant (p<0.05). In logistic regression analysis one point increase of SOFA (p<0.001, OR:1.861, 95%CI:1.403-2.468) and CURB-65 scores (p=0.002, OR:2.484, 95%CI:1.401-4.406) were found as statistically significant for 30-day mortality. In mortal patients, there were significant difference between the baseline, day 3, 7 and 14 results of D-dimer (p=0.01), Ferritin (p=0.042), leucocyte (p=0.019) and neutrophile count (p=0.007). Conclusion: In our study, SOFA and CURB-65 scores on admission were associated with mortality and these score systems might be useful tools for the prognosis in COVID-19 patients.In addition to this, D-dimer, Ferritin, leucocyte and neutrophile counts were significantly increased during the follow up in patients with mortality.
31 Mar 2022Published in The Journal of Infection in Developing Countries volume 16 issue 03 on pages 409-417. 10.3855/jidc.15845